Skip to main content
. 2018 Jun 22;9(48):28903–28909. doi: 10.18632/oncotarget.25627

Figure 3. Temporal occurrence of treatment-related adverse events (Diamond) in months.

Figure 3

Bar = median, CK = creatine kinase.